chronic lymphocytic leukemia

Showing NaN - NaN of 40

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in United States (P-CD19CD20-ALLO1, Rimiducid)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • +5 more
  • La Jolla, California
  • +7 more
Aug 25, 2023

Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (drug, other, biological)

Active, not recruiting
  • Anemia
  • +2 more
  • Birmingham, Alabama
  • +795 more
Jan 28, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (Ublituximab, Umbralisib, Venetoclax)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Birmingham, Alabama
  • +49 more
Jan 20, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Canada, United States (biological, other, drug)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Obinutuzumab
  • +3 more
  • Birmingham, Alabama
  • +484 more
Aug 24, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (Obinutuzumab, Ublituximab, TGR-1202)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Obinutuzumab
  • +3 more
  • Huntsville, Alabama
  • +153 more
Aug 19, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in United States (TGR-1202, TGR-1202 + Ublituximab)

Terminated
  • Chronic Lymphocytic Leukemia
  • Non Hodgkin Lymphoma
  • Huntsville, Alabama
  • +16 more
Jul 20, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Pirtobrutinib, Venetoclax, Rituximab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Phoenix, Arizona
  • +116 more
Jun 27, 2022

Lymphoma, B-Cell, Chronic Lymphocytic Leukemia Trial in United States (FT596, Cyclophosphamide, Fludarabine)

Recruiting
  • Lymphoma, B-Cell
  • Chronic Lymphocytic Leukemia
  • Chicago, Illinois
  • +8 more
Jun 21, 2022

Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Myeloma Trial in Nashville (Patient-reported outcome measure,

Recruiting
  • Chronic Myeloid Leukemia
  • +3 more
  • Patient-reported outcome measure
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jun 1, 2022

Chronic Lymphocytic Leukemia Trial in Israel, United States (Ublituximab, Ibrutinib)

Completed
  • Chronic Lymphocytic Leukemia
  • Huntsville, Alabama
  • +87 more
Apr 25, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Chandler, Arizona
  • +107 more
Mar 8, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Duvelisib, Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • La Jolla, California
  • +91 more
Dec 14, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Zanubrutinib, Ibrutinib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Little Rock, Arkansas
  • +144 more
Dec 3, 2021

Glioblastoma Multiforme, Squamous Cell Carcinoma of Head and Neck, Prostate Cancer Trial in Worldwide (CC-115)

Completed
  • Glioblastoma Multiforme
  • +5 more
  • Los Angeles, California
  • +16 more
Oct 4, 2021

Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Idelalisib,

Completed
  • Indolent Non-Hodgkin's Lymphoma
  • +2 more
  • Huntsville, Alabama
  • +10 more
Feb 22, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (IPI-145 (duvelisib), Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • La Jolla, California
  • +68 more
Mar 15, 2021

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in Canada, United States (Entospletinib

Terminated
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Entospletinib MM
  • Entospletinib SDD
  • Birmingham, Alabama
  • +47 more
Nov 2, 2020

Chronic Lymphocytic Leukemia, Small-Cell Lymphoma Trial in Worldwide (Ibrutinib, Obinutuzumab, Chlorambucil)

Completed
  • Chronic Lymphocytic Leukemia
  • Small-Cell Lymphoma
  • La Jolla, California
  • +70 more
Aug 27, 2020

Connectâ„¢ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Completed
  • Chronic Lymphocytic Leukemia
    • Pomona, California
    • +164 more
    May 8, 2020

    Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin Trial in United States (Idelalisib)

    Terminated
    • Chronic Lymphocytic Leukemia
    • Lymphoma, Non-Hodgkin
    • Huntsville, Alabama
    • +17 more
    Aug 22, 2019

    Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib)

    Terminated
    • Chronic Lymphocytic Leukemia
    • Huntsville, Alabama
    • +44 more
    Aug 12, 2019

    Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Ofatumumab)

    Terminated
    • Chronic Lymphocytic Leukemia
    • Duarte, California
    • +79 more
    Aug 5, 2019

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (TG02 citrate)

    Completed
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • TG02 citrate
    • Augusta, Georgia
    • +4 more
    Jul 23, 2019